Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.85 USD | +0.10% | -3.46% | -20.45% |
17/04 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
15/04 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
Sales 2024 * | 2.83B 236B | Sales 2025 * | 3.23B 269B | Capitalization | 10.82B 902B |
---|---|---|---|---|---|
Net income 2024 * | -161M -13.42B | Net income 2025 * | 6M 500M | EV / Sales 2024 * | 4.35 x |
Net Debt 2024 * | 1.5B 125B | Net Debt 2025 * | 1.08B 90.37B | EV / Sales 2025 * | 3.69 x |
P/E ratio 2024 * |
-67
x | P/E ratio 2025 * |
2,257
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.99% |
Latest transcript on Exact Sciences Corporation
1 day | +0.10% | ||
1 week | -3.46% | ||
Current month | -14.78% | ||
1 month | -12.01% | ||
3 months | -8.45% | ||
6 months | -1.46% | ||
Current year | -20.45% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18/09/18 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 06/18/06 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 01/15/01 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18/09/18 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 22/20/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 58.85 | +0.10% | 2,019,062 |
25/24/25 | 58.79 | -7.04% | 2,648,606 |
24/24/24 | 63.24 | -0.46% | 1,213,600 |
23/24/23 | 63.53 | +1.79% | 1,777,688 |
22/24/22 | 62.41 | +2.38% | 1,594,417 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M | |
+13.32% | 332M |
- Stock Market
- Equities
- EXAS Stock